Skip to content

Effects of esketamine on neurocognitive function and lung function in patients undergoing long-term laparoscopic surgery

Effects of esketamine on neurocognitive function and lung function in patients undergoing long-term laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100630
Enrollment
Unknown
Registered
2025-04-11
Start date
2025-04-14
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative neurocognitive disorders and acute lung injury

Interventions

Esketamine group:In the esketamine group, 0.25mg/kg esketamine was given during anesthesia induction, and 0.2mg/kg/h of esketamine was continuously injected intravenously after endotracheal intubation
Control group:The control group was given equal volume of normal saline at the induction and maintenance of anesthesia, and stopped 30 minutes before the end of the operation.

Sponsors

Tianjin Union Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Elective laparoscopic surgery is planned, and the duration of pneumoperitoneum is expected to be >=3h; 2. Pneumoperitoneum pressure reaches IAH standard (>=12 mmHg); 3. Age>=18 years old, male or female; 4. American Society of Anesthesiologists (ASA) grade I~III; 5. No history of esketamine allergy; 6. Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with BMI 30kg/m^2; 2. Patients at risk of severe elevated blood pressure or intracranial pressure; 3. Patients with poorly controlled or untreated hypertension, such as systolic blood pressure (SBP) > 180 mmHg or diastolic blood pressure (DBP) > 110 mmHg, heart rate (HR) > 120 beats/min; 4. Patients with neuropsychiatric diseases, neurocognitive disorders and poor compliance before surgery; 5. Abnormal liver and kidney function: abnormal liver function is defined as aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) levels exceeding 1.5 times the upper limit of normal (ULN), and renal function abnormalities are defined as serum creatinine (Cr) >=1.5 times ULN; 6. Patients with abnormal preoperative chest CT and arterial blood gas analysis results; 7. History of drug abuse; 8. Those who participate in other studies at the same time, or who have not signed the informed consent form.

Design outcomes

Primary

MeasureTime frame
Incidence of delayed neurocognitive recovery;Chest CT imaging changes;

Secondary

MeasureTime frame
Incidence of postoperative delirium;Levels of markers of intestinal barrier damage in the blood;Levels of markers of nerve damage in the blood;Arterial blood oxygenation level;Ventilation/blood flow ratio;Exhaled nitric oxide levels;Levels of intestinal bacteria metabolites in the blood;Levels of markers of lung injury in the blood ;Postoperative pain score;

Countries

China

Contacts

Public ContactZhao Tingting

Tianjin Union Medical Center

xttxhnmdl@163.com+86 139 2069 2762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026